2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Tyson Foods agreed to sell $1.0 billion of senior notes in two $500 million tranches, a 5.100% series due 2031 and a 5.600% series due 2037, under an underwriting agreement dated August 10, 2026. The company plans to use the net proceeds to purchase notes tendered in a contemplated tender offer, with any remainder used for general corporate purposes. The offering is expected to close on August 24, 2026, subject to customary closing conditions.
Two $500 million tranches: 5.100% senior notes due 2031 and 5.600% senior notes due 2037
Underwriters include BofA Securities, J.P. Morgan, Morgan Stanley and Rabo Securities as representatives
Expected closing date is August 24, 2026
Net proceeds are intended for a contemplated tender offer, with any remainder for general corporate purposes
NextEra Energy filed Dominion Energy's financial statements and unaudited pro forma combined financial information to support its pending merger with Dominion Energy, first disclosed in a May 18, 2026 Form 8-K. The filing estimates total merger consideration at $65,218 million, based on NEE's July 30, 2026 closing price of $87.93, and the figures are preliminary. Completion still requires shareholder approvals and several regulatory approvals, so shareholders of both companies face a deal that is not yet closed.
Each Dominion Energy share converts into $360 million in aggregate cash (pro rata) plus 0.8138 shares of NEE common stock.
Estimated merger consideration is $65,218 million, including about 738 million NEE shares valued at $64,858 million, based on NEE's $87.93 closing price on July 30, 2026.
Preliminary goodwill is $40,053 million, and a 10% change in NEE's stock price would move estimated consideration by about $6,484 million.
Closing requires approvals including Dominion and NEE shareholder votes, HSR Act clearance, and approvals from FERC, the NRC, the Virginia SCC, the North Carolina Utilities Commission and the South Carolina PSC.
Azenta, Inc. appointed Erik J. Bello as Vice President and Chief Accounting Officer, with his employment expected to begin August 31, 2026. CFO Lawrence Lin will stop serving as principal accounting officer on that date but will remain Executive Vice President and Chief Financial Officer. The filing describes a routine accounting leadership change with no financial results included.
Erik J. Bello, age 51, was appointed by the Board on August 6, 2026; employment expected to start August 31, 2026
Bello's offer letter sets a $380,000 annual base salary and an $80,000 one-time sign-on bonus
Bello's incentive target is 50% of base salary, with long-term awards of $150,000 for the current fiscal year and $300,000 for the following year
Lawrence Lin ceases as principal accounting officer but remains CFO
An entity controlled by Stellex Capital Management agreed to buy all 1,604,326 common shares held by Corre Partners Management and its affiliates at $35.50 per share in a privately negotiated sale. Team, Inc. issues no shares and receives no proceeds, and Stellex is expected to own about 35% of the outstanding common stock upon closing, along with preferred stock and warrants it received in September 2025. Separately, Corre irrevocably waived its board observation and nomination rights, including the right to designate the Chairman, effective August 6, 2026.
Stellex-controlled entity to acquire 1,604,326 common shares from Corre at $35.50 per share.
Team, Inc. will not issue shares or receive proceeds from the transaction.
Upon closing, Stellex is expected to own about 35% of common stock, plus preferred stock and warrants issued in September 2025.
Corre waived its board observation and nomination rights, including the right to designate the Chairman, effective August 6, 2026; rights tied to the Lender Director remain in place.
On August 3, 2026, East West Ave Acquisition Corp., a blank check company, closed its initial public offering of 10,000,000 units at $10.00 per unit, generating $100,000,000 in gross proceeds, and sold 272,500 private units to its sponsors for $2,725,000. The filing says $100,500,000 was placed in a trust account with Equiniti Trust Company, LLC, which holds the funds until a business combination or redemption. The company has not commenced operations, and its auditor included a going concern paragraph, meaning substantial doubt about its ability to continue, tied to the deadline to complete a business combination.
10,000,000 units sold at $10.00 each for $100,000,000 gross proceeds; each unit has one common share and one right to exchange for one-fourth of a common share upon a business combination
272,500 private units sold to sponsors East West Avenue LLC and NFR Capital Limited for $2,725,000
$100,500,000 placed in trust account; $867,845 in cash held outside the trust as of August 3, 2026
Company has until August 3, 2027 to complete an initial business combination, extendable to November 3, 2027; auditor Fortune CPA, Inc. cited substantial doubt about going concern
UGI Corporation's Compensation and Talent Development Committee approved a new Executive Short-Term Incentive Bonus Plan on August 4, 2026, replacing several prior executive annual bonus plans across the company and its subsidiaries. The change alters how senior executives can earn annual bonuses, which shareholders may watch as part of pay design, but the filing reports no financial results or dollar amounts.
Committee approved the Bonus Plan on August 4, 2026; it takes effect October 1, 2026.
The plan supersedes the UGI Executive Annual Bonus Plan, AmeriGas Executive Annual Bonus Plan, and UGI Utilities Executive Annual Bonus Plan.
Bonuses are a percentage of base salary and depend on meeting annual Performance Goals and service criteria.
Executive officers under Section 16 of the Exchange Act are all Participants in the plan.
On August 10, 2026, MPT's operating partnership closed a private placement and private exchange issuing $2.4 billion of 9.25% senior secured notes due February 15, 2032. The company said proceeds will fund the full redemption of its 2026 senior notes and a partial redemption of its 2027 senior notes, and the exchange refinanced about $1.5 billion of unsecured notes maturing from 2027 to 2031.
$2.4 billion aggregate principal of 9.25% senior secured notes due February 15, 2032, issued August 10, 2026
Proceeds to fully redeem 2026 senior notes and partly redeem 2027 senior notes; private exchange refinanced about $1.5 billion of 2027–2031 unsecured notes
Interest paid semi-annually on June 15 and December 15, starting December 15, 2026; holders may require repurchase at 101% upon a change of control
Cogent Biosciences filed a prospectus supplement on August 10, 2026, covering the offer and sale of up to $400,000,000 of common stock through Guggenheim Securities under an existing sales agreement. The offering runs under an automatic shelf registration statement filed November 7, 2025, and the filing does not state a price or timing for any sales. For shareholders, this sets up a possible source of new shares that could dilute existing holdings if sold.
Up to $400,000,000 of common stock may be sold through Guggenheim Securities, as sales agent or principal, at market prices.
The prospectus supplement was filed August 10, 2026, under Form S-3ASR (File No. 333-291384).
Gibson, Dunn & Crutcher LLP issued a legal opinion on the shares (Exhibit 5.1).
Hadron Energy appointed Eric Williams, previously executive vice president and chief operating officer at TerraPower, as its executive vice president of engineering, effective when his employment starts on August 31, 2026. His approved base salary is $400,000 with a 40% target bonus, and the filing excludes any future equity awards.
Eric Williams, age 51, joins from TerraPower, where he was executive vice president and chief operating officer
Base salary of $400,000 and a target bonus of 40% of base salary
Employment starts August 31, 2026; annual bonus plan still to be established by the Board
Jazz subsidiary Jazz Pharmaceuticals, Inc. agreed on August 10, 2026 to acquire Actio Biosciences, Inc. through a merger, with Actio becoming a wholly owned subsidiary. The upfront value starts at an initial $820 million, adjusted for items such as cash, debt and unpaid expenses, and holders may also receive up to $500 million in milestone payments tied to ABS-1230. Completion depends on conditions including HSR antitrust clearance, approval by holders of at least 85% of Actio's shares, and a spin-out of non-ABS-1230 programs.
Initial aggregate upfront value of $820 million, subject to cash, debt, unpaid expense and tax adjustments
Up to $500 million in milestones: $250 million on regulatory approval for KCNT1-Related Epilepsy, $100 million at $500 million annual net sales, and $150 million at $1 billion annual net sales
Closing requires completion of a spin-out of non-ABS-1230 programs into a new company in which Parent takes a minority stake
If the merger has not closed by an End Date five months after signing, either party may terminate; the agreement contains no termination fees
GEN Restaurant Group entered a Sales Agreement with Roth Capital Partners on August 10, 2026, allowing it to sell up to $3,740,000 of Class A common stock through the agent over time. The company pays a 3.0% commission on gross proceeds and is not obligated to sell any shares, so the actual dilution to shareholders depends on how much it chooses to sell.
Maximum aggregate offering amount of up to $3,740,000 of Class A common stock through Roth Capital Partners, LLC
Agent commission of 3.0% of gross proceeds, plus certain agent expenses paid by the company
Proceeds intended for expanding the consumer packaged goods business, working capital, and general corporate purposes, which may include new restaurant openings
Shares sold under a Form S-3 shelf registration declared effective May 27, 2026, with a prospectus supplement dated August 10, 2026
Crexendo, Inc. posted an investor presentation dated August 10, 2026 to its investor website and furnished it to the SEC as Exhibit 99.1 to a Form 8-K. The filing contains no financial results, guidance, or other new figures in its text, and the company states the material is not deemed filed under Section 18 of the Exchange Act.
Investor presentation posted to www.crexendo.com/investor on August 10, 2026
Presentation attached as Exhibit 99.1; filing signed by CFO Ronald Vincent on August 10, 2026
Filing states the information is furnished, not filed, and does not admit materiality
Shareholders of XAI Floating Rate & Alternative Income Trust (XFLT) approved a new investment sub-advisory agreement with Rockford Tower Asset Management, L.L.C. at a reconvened special meeting on August 6, 2026, after the meeting was adjourned to gather more proxy votes. The agreement was signed August 10, 2026, and its terms are substantially the same as the interim agreement from July 30, 2026, except for the term, which is two years initially.
Shareholders approved the New Sub-Advisory Agreement at the reconvened special meeting on August 6, 2026, after an earlier adjournment to solicit more proxies.
The New Sub-Advisory Agreement was entered into on August 10, 2026, among the Trust, XA Investments, LLC and Rockford Tower Asset Management, L.L.C.
The agreement has an initial two-year term, then renews annually, and can be terminated by either the Trust or Adviser or the sub-adviser on 60 days' written notice.
An affiliate of CEO Lei Wu has so far executed a prepaid variable forward transaction on 286,058 of the up to 700,000 Class A shares it previously disclosed, citing unfavorable market conditions. The affiliate has approval to complete the remaining 413,942 shares in the Company's next open trading window and no later than September 30, 2026, subject to market conditions. The Company says it will not sell shares or issue new shares in the transaction, and the cap of 700,000 shares is unchanged.
Executed so far: 286,058 PVFC Shares; remaining: 413,942 PVFC Shares
Remaining shares to be executed in the next open trading window and no later than September 30, 2026
Maximum covered remains 700,000 shares; original execution target was June 29, 2026
CEO says he has no present intention to sell additional shares beyond the 700,000 during the 12 months after June 29, 2026
Commercial Vehicle Group promoted Angie O'Leary, who has served as interim Chief Financial Officer since March 2026, to permanent EVP and Chief Financial Officer effective August 6, 2026. The filing gives her a $425,000 base salary, a 65% target bonus and a long-term incentive opportunity of at least 120% of base salary beginning in 2027, which shows the board's decision to make the role permanent.
Angie O'Leary, age 45, promoted to EVP and Chief Financial Officer, effective August 6, 2026
Served as interim CFO since March 2026 and previously as Senior Vice President, Corporate Controller and Chief Accounting Officer since December 2020
Base salary $425,000; target bonus 65% of base salary; long-term incentive of no less than 120% of base salary beginning in 2027; change-in-control severance equal to 12 months
Press release dated August 10, 2026 announced the appointment; CEO James Ray said the company is pleased to appoint her as permanent CFO
Restaurant Brands International said its subsidiary RBI LP received an irrevocable exchange notice from 3G Restaurant Brands Holdings LP, an affiliate of 3G Capital, covering 2,784,549 Class B exchangeable units. RBI LP intends to repurchase these units for cash on hand, with the exchange scheduled for August 31, 2026, which would cancel the units and reduce fully diluted common shares. After the exchange, RBH would hold approximately 21% of RBI's fully diluted common shares.
Exchange notice covers 2,784,549 Class B exchangeable limited partnership units of RBI LP
RBI LP plans to satisfy the notice by repurchasing the units for cash, using available cash on hand
Exchange date is scheduled for August 31, 2026; repurchase price is based on the 20-day volume weighted average price on the NYSE
After the exchange, RBH would hold approximately 21% of RBI's fully diluted common shares
Innovex International entered an underwriting agreement with Amberjack Capital Partners affiliates and Barclays Capital for the sale of 5,000,000 common shares by the selling stockholders. The company sold no shares and received no proceeds, so the offering does not add new shares or cash to the company.
Selling stockholders are affiliates of Amberjack Capital Partners, L.P.; the company received no proceeds
5,000,000 shares offered at a price to the underwriter of $28.71 per share
Underwriting agreement dated August 6, 2026; offering closed August 10, 2026
Offering made under an effective Form S-3 shelf registration (File No. 333-282178)
Progressive released a report on its Catastrophe Reinsurance Program on August 10, 2026, describing its reinsurance practices and the program it completed placing for June 1, 2026 to May 31, 2027. The Board also declared a quarterly common share dividend of $0.10 per share, payable October 9, 2026, to shareholders of record on October 1, 2026. The filing furnishes the report under Regulation FD and does not report new financial results.
Quarterly dividend of $0.10 per share declared August 7, 2026; payable October 9, 2026 to holders of record on October 1, 2026
Property per Occurrence XOL program retention is $300 million for a first event outside Florida and $75 million for a first event in Florida
Coverage limits, net of retention, are $1.85 billion for a first event outside Florida and $2.19 billion for a first event in Florida
Program renewed June 1, 2026 and covers losses occurring June 1, 2026 through May 31, 2027
Public Storage appointed S. Wade Sheek as its Chief Legal Officer and Corporate Secretary, effective August 17, 2026, replacing Nathaniel A. Vitan. Sheek most recently served as Senior Vice President, Chief Legal Officer and Secretary of Herc Holdings, Inc. Vitan will remain as a senior advisor until October 1, 2026 to support the transition.
S. Wade Sheek appointed Chief Legal Officer and Corporate Secretary, effective August 17, 2026
Sheek previously served as Senior Vice President, Chief Legal Officer and Secretary of Herc Holdings, Inc.
Nathaniel A. Vitan, the current Chief Legal Officer and Corporate Secretary, will stay on as senior advisor until October 1, 2026
V2X, Inc. disclosed that Senior Vice President and Chief Growth Officer L. Roger Mason Jr. resigned effective immediately on August 7, 2026, to serve as Director of the National Reconnaissance Office. CEO Jeremy C. Wensinger will assume his responsibilities until a successor is appointed, and the company says the resignation was not due to any disagreement on operations, policies or practices.
Mason resigned as Chief Growth Officer and from all subsidiary positions, effective immediately on August 7, 2026.
Mason received an AIP Payment of $331,975, a prorated portion of his 2026 Annual Incentive Plan award at target for January through July 2026.
Mason signed a separation agreement and general release dated August 6, 2026; the full text is filed as Exhibit 10.1.
CEO Jeremy C. Wensinger will assume Mason's role until a successor is appointed.
On August 10, 2026, Annexon appointed retinal surgeon Mark S. Blumenkranz, M.D., M.S.S., to its board of directors, effective immediately. The appointment followed the resignation of director Muneer Satter, who also left the audit committee and stepped down as chair of the nominating committee, and the filing states his resignation was not due to any disagreement with the company. The filing reports no financial results; for shareholders, the change concerns board composition and director pay terms.
Mark S. Blumenkranz, M.D., M.S.S., joined the board effective August 10, 2026, as a Class II director with a term expiring at the 2028 annual meeting, and was also appointed to the Audit Committee and Science and Technology committee.
Muneer Satter resigned from the board, the Audit Committee, and as chair of the Nominating Committee; the company said he served more than eleven years and joined the board in 2015.
Dr. Blumenkranz receives a $40,000 annual retainer, an annual option grant of 65,000 shares, and a 175,000-share stock option granted in lieu of the standard initial grant.
Viant Technology's board elected Craig Abrahams as a Class I director, effective August 10, 2026, and appointed him to the Audit Committee. He receives an initial restricted stock unit grant with a grant date fair value of $400,000 and an additional prorated grant valued at $185,000 in total terms, under the company's standard non-employee director pay policy.
Craig Abrahams elected Class I director by the board on August 5, 2026, effective August 10, 2026
Appointed to the Audit Committee of the Board
Initial RSU grant has a grant date fair value of $400,000
Additional RSU grant is his prorated portion of $185,000
Construction Partners (ROAD) said director Michael H. McKay, a member of its Audit Committee, died on July 22, 2026, leaving the committee with two independent directors. Nasdaq requires at least three, so the company is out of compliance but intends to use a cure period to restore compliance.
Nasdaq Listing Rule 5605(c)(2)(A) requires at least three independent Audit Committee members; the company now has two.
The cure period ends on the earlier of the next annual stockholder meeting or July 22, 2027.
On August 6, 2026, the company issued 619,000 restricted Class B shares to employees, vesting September 30, 2030.
On August 6, 2026, MasTec agreed to sell $650 million of 5.850% senior unsecured notes due September 30, 2036, priced at 99.656%. The company intends to use the net proceeds to repay some or all of its $600 million term loan maturing June 26, 2028, with closing expected on August 17, 2026, subject to customary conditions.
$650 million aggregate principal of 5.850% senior notes due September 30, 2036, priced at 99.656%
Interest payable semi-annually; closing expected August 17, 2026, subject to customary conditions
Net proceeds intended to repay some or all of a $600 million term loan maturing June 26, 2028, plus fees and expenses
Representatives of the underwriters are PNC Capital Markets LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC
Pinnacle Acquisition Corporation, a blank check company, closed its initial public offering of 20,000,000 units at $10.00 per unit on August 6, 2026, for gross proceeds of $200,000,000. The full $200,000,000 was placed in a trust account, which can be released only on completing an initial business combination or on redemption if no combination is completed within 21 months of the IPO closing, so shareholder funds stay restricted until a deal or liquidation.
20,000,000 units sold at $10.00 each, for gross proceeds of $200,000,000; units began trading on the NYSE on August 7, 2026 under PNAQ.U
Sponsor PAC Sponsor, LLC bought 225,000 private placement units for $2,250,000 at closing
$200,000,000 placed in a trust account with Continental Stock Transfer & Trust Company; includes up to $6,000,000 of deferred underwriter discount and commissions
Andrew Rechtschaffen, Karen Martin, Paul Stoyan and Harry Brandler joined the board on August 6, 2026, alongside Steven K. Hudson
NIKE said its Vice President, Chief Accounting Officer and Corporate Controller, Johanna Nielsen, will resign effective September 4, 2026, to pursue another opportunity, and that the resignation is not due to any disagreement with the company. Executive Vice President and CFO David Denton will also serve as Interim Corporate Controller and principal accounting officer until the board appoints a successor, and his compensation is not changing for that role.
Johanna Nielsen informed NIKE on August 4, 2026 of her intent to resign, effective September 4, 2026.
The filing states her resignation is not the result of any disagreement with the company over operations, policies or practices.
David Denton, EVP and CFO, becomes Interim Corporate Controller as of September 4, 2026, and principal accounting officer until a successor is appointed.
Mr. Denton's compensation is not being adjusted for the interim controller role; his CFO appointment was reported in an 8-K filed June 23, 2026.
Celsius Holdings said its President and Chief Operating Officer, Eric Hanson, has departed the company effective August 10, 2026, and that he is eligible for severance under the Executive Severance Pay Plan, subject to plan conditions. The company also named Tyler Bohannon Chief Commercial Officer and created a Chief Business Transformation Officer role for Tony Guilfoyle, reshaping senior leadership as it pursues its total energy portfolio strategy. The filing includes no financial results or guidance, so its direct effect on shareholders is limited to the leadership change.
Eric Hanson, President and Chief Operating Officer, departed effective August 10, 2026, and is eligible for severance under the Executive Severance Pay Plan, subject to conditions
Tyler Bohannon, previously EVP of North American Sales since February 2025, was appointed Chief Commercial Officer effective August 10, 2026
Tony Guilfoyle, former Chief Customer Officer, was appointed to the newly created role of Chief Business Transformation Officer effective July 1, 2026
At its August 6, 2026 annual meeting, NVE shareholders elected all seven director nominees and approved executive pay and the auditor ratification. Daniel Baker retired as CEO under the previously announced succession plan, and Peter Eames became president and CEO while Baker became board chairman.
Daniel A. Baker retired as president and CEO effective at the shareholders' meeting and was elected chairman of the board.
Peter G. Eames was elected to the board and appointed president and chief executive officer.
Carolyn W. Valentine was elected to the board for the first time and appointed to the Compensation and Nominating/Corporate Governance committees; board size rose from five to seven.
Named executive officer compensation was approved with 3,011,073 votes for and 73,720 against; Boulay PLLP was ratified as auditor with 3,876,455 votes for.
On August 10, 2026, Alphabet closed an underwritten public offering of $25 billion in U.S. dollar senior notes issued under an existing 2016 indenture with The Bank of New York Mellon Trust Company as trustee. The offering includes ten tranches, both floating rate and fixed rate, with maturities from 2028 to 2066. The filing does not state how Alphabet will use the proceeds.
Total principal amount of $25 billion across ten tranches
Fixed rate notes carry coupons from 4.500% (due 2028) to 6.500% (due 2066)
Largest tranches are $4.5 billion of 5.450% notes due 2036 and $4.5 billion of 6.375% notes due 2056
Issued under an indenture dated February 12, 2016, with The Bank of New York Mellon Trust Company, N.A., as trustee
CoreWeave's subsidiary CoreWeave Financing DDTL V-V, LLC entered into a credit agreement on August 7, 2026 for a $2.6 billion delayed draw term loan facility, which the company announced as closed on August 10, 2026. The facility was used primarily to finance capital expenditures for customer contracts, including GPU servers and related infrastructure, and the parent guarantees the obligations, which are secured by substantially all of the borrower's assets. The new debt adds a secured obligation with a debt service coverage covenant of at least 1.35x, which shareholders may want to weigh against the company's other borrowings.
Facility size is $2.6 billion, available in draws until the commitment termination date in December 2026
Maturity date is September 1, 2031; priced at Term SOFR plus a 5.50% margin, with a 0.50% annual undrawn fee
Parent CoreWeave, Inc. guarantees all obligations; debt service coverage ratio must be at least 1.35x starting after the earlier of full commitment reduction or December 31, 2026
Facility received Ba2 from Moody's and BB+ from Fitch, according to the press release
Jewett-Cameron Trading Company appointed Scott Kotarba to its Board of Directors, effective August 10, 2026, to fill the seat vacated by Ian Wendler's retirement on July 31, 2026. Independent director Subriana Pierce was also added to the Audit Committee effective August 7, 2026, and the board now has five members, three of them independent.
Scott Kotarba, managing member of Kotarba Partners & Co., joins the board effective August 10, 2026 as a non-independent director
Kotarba has been a company consultant since April 2026 and will receive $12,000 annually plus 25 restricted shares per quarter as a director
Subriana Pierce was appointed to the Audit Committee effective August 7, 2026, which has three independent directors per NASDAQ Rule 5605-3
Teradyne entered a five-year, $1.0 billion senior secured revolving credit facility with PNC Bank, National Association, as administrative agent, on August 7, 2026. The company has not borrowed under the facility, which can fund working capital and general corporate purposes.
No borrowings made under the facility as of the filing
Financial covenants include a maximum consolidated leverage ratio of 3.50:1.00 (4.00:1.00 after an acquisition over $200 million) and a minimum interest coverage ratio of 2.50:1.00
Collateral and guarantees are released if the company reaches investment grade ratings from at least two of S&P, Moody's and Fitch
ADTRAN Holdings' majority-owned unit Adtran Networks SE amended the employment agreement of Chief Technology Officer Christoph Glingener on August 10, 2026. The amendment extends the term through December 31, 2026, keeps his base salary at €400,000, and sets new incentive and equity awards tied to revenue, Adjusted EBIT and relative total shareholder return.
Base salary remains €400,000; total annual remuneration capped at €2,800,000.
Target long-term financial plan PSU award of €903,729, covering performance from January 1, 2026 through December 31, 2028, with a cap of €2,000,000.
Annual RSU target equal to 75% of base salary, capped at €903,729; cash bonus target equal to 60% of base salary.
The Compensation Committee does not intend to grant annual market-based PSUs to named executive officers going forward.
American Healthcare REIT, through its operating partnership, signed three purchase agreements on August 10, 2026 to acquire eight senior housing communities, called the Kensington Portfolio, for an aggregate price of $873 million. The company expects the first closing, covering the portfolio, in the third quarter of 2026, with the remaining two closings expected by the end of 2026, but it gives no assurance that any closing will occur on that timeline or at all.
Eight senior housing communities with 745 units in California, Maryland, New York and Virginia, for an aggregate price of $873,000,000
Total deposits of $8,730,000 go into escrow within three business days of August 10, 2026 and become non-refundable under specified conditions
Initial closing of the Portfolio Agreement is set for September 1, 2026, with a one-time option to extend to October 15, 2026
Kensington Park and Bethesda closings depend on lender consent on a $56,460,000 existing loan and a stabilization condition, respectively
Skyworks Solutions issued $2.0 billion of senior notes in three tranches due 2028, 2032 and 2036, to help finance about $3.00 billion in cash consideration for its planned acquisition of Qorvo. The 2028 and 2036 notes carry a special mandatory redemption if the Qorvo merger is not completed, which shifts some financing risk back to the company if the deal fails.
Issued $800 million of 5.000% notes due 2028, $600 million of 5.750% notes due 2032 and $600 million of 6.250% notes due 2036
Proceeds, together with existing cash, are intended to fund about $3.00 billion in cash consideration for the Qorvo merger
2028 and 2036 notes must be redeemed early if the Qorvo merger does not close by 11:59 p.m. Pacific Time on November 3, 2027, or if the company abandons or the merger agreement is terminated
Notes were issued under an indenture with U.S. Bank Trust Company, National Association, as trustee
Amneal Pharmaceuticals completed its acquisition of Kashiv BioSciences on August 10, 2026, paying in part with 28,942,098 newly issued Class A shares. The company also borrowed a $350 million incremental term loan, with proceeds used as part of the purchase consideration, and says the deal adds a long-term biosimilars growth pillar. The filing does not disclose financial results or the total purchase price, so the effect on earnings and the share count is not yet quantified.
Acquisition of Kashiv BioSciences, LLC closed on August 10, 2026, under a Membership Interest Purchase Agreement dated April 21, 2026
Amneal issued 28,942,098 shares of Class A Common Stock to the sellers in a private placement exempt from registration
$350 million incremental term loan made by Bank of America, N.A. under Amendment No. 4 to the Term Loan Credit Agreement with JPMorgan Chase Bank, N.A. as agent
Amneal plans to file Kashiv financial statements and pro forma information by amendment, and to register the shares for resale on Form S-3
On August 10, 2026, Southwest Airlines appointed Varun Krishna and Jason T. Liberty to its Board of Directors, effective immediately, and increased the Board to thirteen members. The filing describes the director compensation package, which includes a $100,000 annual retainer and flight travel privileges, but does not indicate any change to business results or operations.
Varun Krishna is CEO of Rocket Companies, Inc. and interim CEO of Redfin; Jason T. Liberty is Chair and CEO of Royal Caribbean Cruises Ltd.
Board size increased to thirteen members, effective immediately on August 10, 2026.
Non-employee directors receive a $100,000 annual retainer, pro-rated for Krishna and Liberty for the June 2026 to May 2027 service period.
Neither new director has been appointed to a Board committee.
Blackbaud's board appointed Anthony W. Boor, its Executive Vice President of Corporate Development and Strategy, as a director effective August 5, 2026. Boor is a former Blackbaud CFO who served from November 2011 to April 2025, so the appointment places a long-time insider on the board while he keeps his operating role.
Appointed to the board on August 5, 2026 as a Class A director, with a term ending at the 2029 annual meeting
Continues as Executive Vice President of Corporate Development and Strategy; annual base salary is $518,578 with a 75% equity incentive bonus target
Previously served as Executive Vice President, Chief Financial Officer and Principal Accounting Officer from November 2011 to April 2025, and as interim CEO from August 2013 to January 2014
Retention agreement provides 1.5 times base salary, equity acceleration and up to 12 months of COBRA premiums if terminated within 12 months after a change in control
Latigo Biotherapeutics, Inc. closed its initial public offering on August 10, 2026, selling 19,200,000 shares of common stock at $18.00 per share. Gross proceeds were approximately $345.6 million before underwriting discounts, commissions and offering expenses. The company also filed an amended and restated certificate of incorporation and adopted amended and restated bylaws in connection with the closing.
IPO: 19,200,000 common shares sold at $18.00 per share on August 10, 2026
Gross proceeds of approximately $345.6 million, before underwriting discounts and expenses
Restated certificate of incorporation filed with the Delaware Secretary of State and restated bylaws adopted, both effective August 10, 2026
Full text of the restated documents filed as Exhibits 3.1 and 3.2
BlossomHill Therapeutics, Inc. closed its initial public offering on August 10, 2026, selling 9,375,000 shares of common stock at $16.00 per share. The company also adopted an amended and restated certificate of incorporation and amended and restated bylaws in connection with the closing. The filing gives gross proceeds before underwriting discounts and offering expenses, which are not yet deducted.
IPO of 9,375,000 shares of common stock at $16.00 per share, closed August 10, 2026
Approximate aggregate gross proceeds of $150.0 million, before underwriting discounts, commissions and estimated offering expenses
Amended and restated certificate of incorporation filed with Delaware Secretary of State; restated bylaws adopted effective August 10, 2026
Restated bylaws were previously filed as Exhibit 3.4 to Form S-1 (File No. 333-297512) on July 17, 2026
On August 7, 2026, the Fidelity Ethereum Fund (FETH) signed custodial agreements with Anchorage Digital Bank NA and BitGo Bank & Trust, N.A., and amended its sponsor and trust agreements to allow staking of the fund's ether. The sponsor expects staking to start as soon as practicable after the registration statement takes effect, with the trust keeping 85% of staking rewards. Shareholders may receive quarterly cash distributions, but the trust may sell rewards or ether to fund them, which could affect its ether exposure and share price or net asset value.
August 7, 2026: trust entered custodial services agreements with Anchorage Digital Bank NA and BitGo Bank & Trust, N.A.
Trust retains 85% of staking rewards; remaining 15% is paid as fees shared among the sponsor, custodians and node operators.
Trust intends to make quarterly cash distributions of net staking income, which may require selling rewards or a portion of its ether.
Staking expected to start as soon as practicable after the Form S-3 registration statement becomes effective.
Mueller Industries declared a regular quarterly cash dividend of 17.5 cents per share, payable September 18, 2026 to shareholders of record on September 4, 2026. The company also said director Gary S. Gladstein will retire from its Board effective December 31, 2026, after a combined 30 years of service, including three years as Chairman and three years as Lead Independent Director.
Regular quarterly cash dividend of 17.5 cents per share declared, announced August 6, 2026
Dividend payable September 18, 2026 to shareholders of record on September 4, 2026
Gary S. Gladstein, who served on the Board from 1990 to 1994 and from 2000, retires effective December 31, 2026
Gladstein was Chairman of the Board from 2013 to 2015 and Lead Independent Director from 2016 to 2018
Werner Enterprises' Board appointed Paul Hoelting, a veteran transportation executive, as a director on August 7, 2026, to fill a Class I vacancy. The filing states his director pay package, but no financial results or guidance are reported, so the appointment itself does not change reported performance.
Board appointed Paul Hoelting on August 7, 2026, to fill a Class I directorship vacancy
Annual pay includes a $75,000 cash retainer and a restricted stock award valued at $100,000 vesting over three years, plus committee chair retainers
Hoelting previously served as President of TForce Freight and held executive roles at UPS Freight, including CFO
Filing reports no arrangements with other persons for his selection and no related-party transactions requiring disclosure
On August 10, 2026, Duolingo increased its board from nine to ten directors and appointed Sallie Krawcheck, former Citigroup CFO and Ellevest founder, as a Class I director and Audit Committee member, effective immediately. The filing discloses her director pay, including cash retainers and restricted stock unit awards, but reports no change to financial results or guidance.
Board expanded from nine to ten directors; Krawcheck's term expires at the 2028 annual meeting
Annual cash retainers of $45,000 for Board service and $10,000 for Audit Committee service
Initial RSU award valued at $450,000, plus a prorated $180,000 RSU award and an annual $215,000 RSU award
Press release describes Krawcheck as having led Ellevest to $2.4 billion in assets under management
Fulcrum Therapeutics said its vice president of finance and principal accounting officer, Greg Tourangeau, is leaving the company, with his tenure ending August 7, 2026. The board named Chief Financial Officer Alan Musso as principal accounting officer, effective the same date, so one executive now holds both the finance and accounting roles.
Greg Tourangeau's tenure as VP, Finance and principal accounting officer ends August 7, 2026, as previously disclosed in a June 11, 2026 8-K.
Board appointed Alan Musso, chief financial officer, as principal accounting officer on August 9, 2026, effective August 7, 2026.
Musso will receive no additional compensation for the added role.
Sight Sciences appointed Kashif Rashid, a former general counsel at Nevro Corp., as Chief Legal Officer and Corporate Secretary effective August 10, 2026. Jeremy Hayden leaves the same roles on that date and stays with the company through August 31, 2026 to help with the transition. For shareholders, the filing discloses the pay terms for the new officer and the severance terms for the departing one.
Rashid's initial base salary is $450,000, with an annual cash bonus target of 50% of base salary.
Rashid is eligible for a restricted stock unit award valued at $1,400,000, vesting in four equal annual installments starting August 10, 2027.
Hayden's separation is contingent on a separation agreement and release; it provides one year of base salary and up to one year of COBRA benefits.
Rashid previously served as General Counsel of Nevro Corp. from December 2017 to January 2024.
Onto Innovation closed its previously announced acquisition of a 27% minority equity stake in Rigaku Holdings Corporation from Atom Investment, L.P., an affiliate of The Carlyle Group, for approximately $720 million. The company will account for the stake under the fair value option and will not consolidate Rigaku's results, and it will nominate a director to Rigaku's board.
Acquired 61,123,436 Rigaku shares, or 27% of issued and outstanding common stock, under an April 21, 2026 Share Purchase Agreement
Aggregate purchase price of approximately $720 million, or 113,078,356,600 yen
Onto will use fair value option accounting and will not consolidate Rigaku's financial results
Applied Aerospace & Defense appointed Chris Rogers, its Chief Growth Officer, as President and Chief Strategy Officer, effective July 27, 2026, with his prior role folded into the new position. CEO Trip Ferguson remains in charge, and Rogers will continue to report to him; the filing states his compensation is unchanged. The change is an internal leadership reorganization that the company says follows its June 2026 IPO, and it does not include financial results.
Chris Rogers, age 51, named President and Chief Strategy Officer, effective July 27, 2026; Board action dated August 7, 2026
Rogers previously served as Chief Growth Officer since December 2025 and was an investment banker at Harris Williams from June 2005 to June 2025
Rogers will continue to report to CEO Trip Ferguson; his existing compensation remains in effect
Company's earnings call is scheduled for August 12, 2026
A federal court in Massachusetts preliminarily approved the settlement of stockholder derivative claims against Evolv Technologies on August 6, 2026. The settlement requires no payment by the company, and it commits Evolv to corporate governance reforms for five years, with plaintiffs' fees of $1,275,000 paid by insurers. A final settlement hearing is set for October 21, 2026, and the settlement takes effect only after final court approval.
Court preliminarily approved the settlement on August 6, 2026; final settlement hearing set for October 21, 2026 at 9:00 a.m.
Company makes no settlement payment; plaintiffs' attorneys' fees and expenses of $1,275,000 to be paid by insurers.
Evolv agreed to governance reforms, including audit committee, marketing policy, disclosure committee and General Counsel changes, to remain in effect for five years.
Replimune agreed on August 9, 2026 to sell 9,701,490 common shares and pre-funded warrants for 2,736,340 shares to underwriters at $12.06 per share. The company expects gross proceeds of about $150 million and net proceeds of about $140.5 million, with closing expected on August 11, 2026. Because the sale adds shares to those already outstanding, existing shareholders' ownership stake will be diluted.
Offering of 9,701,490 common shares at $12.06 per share, plus pre-funded warrants for 2,736,340 shares at $12.0599 per warrant
Expected gross proceeds of about $150 million; estimated net proceeds of about $140.5 million after underwriting discounts and offering expenses
Underwriters are Leerink Partners LLC, J.P. Morgan Securities LLC, and Cantor Fitzgerald & Co.; closing expected on or about August 11, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.